Replacing Medicare visual acuity screening with dilated eye exams appears cost effective

Replacing visual acuity screenings for new Medicare enrollees with coverage of a dilated eye exam for healthy patients entering the government insurance program for the elderly "would be highly cost-effective," suggests a study being published Online First by the Archives of Ophthalmology.

People can enroll in Medicare after they turn 65 and are supposed to receive a visual acuity screening and other preventive as part of a Welcome to Medicare within 12 months of enrollment. In 2009, the U.S. Preventive Services Task Force reversed its 1996 recommendation in favor of visual acuity screening because of insufficient evidence to support it. Whether Medicare will continue to include visual acuity screening in its initial preventive physical examination is undetermined.

"Our results support the conclusions of the U.S. Task Force that currently recommended visual acuity screening in primary care settings cannot be demonstrated to result in meaningfully different outcomes than no screening," the study suggests.

David B. Rein, Ph.D., of Public Health Research at NORC at the University of Chicago, and colleagues used a Monte Carlo cost-effectiveness with a total of 50,000 simulated patients with demographic characteristics matched to people 65 years old. They excluded patients with diabetes because the cost-effectiveness of visual screening for these patients has been established. They also excluded patients with diagnosed eye disease.

The study results suggest that compared with a no-screening policy, dilated eye evaluations increased quality-adjusted life years (QALYs) by 0.008 and increased costs by $94. A visual acuity screening increased QALYs in less than 95 percent of the simulations and increased total costs by $32 per person.

"Our research suggests that the current policy of visual acuity screening is a suboptimal use of resources and that replacing this policy with coverage of a dilated eye evaluation for all healthy patients entering Medicare would be highly cost-effective," researchers conclude.

More information: Arch Ophthalmol. Published online January 9, 2012. doi:10.1001/archopthalmol.2011.1921

add to favorites email to friend print save as pdf

Related Stories

Study: Many elderly get colon screening too often

May 09, 2011

(AP) -- Many older Americans get repeat colon cancer tests they don't need and Medicare is paying for it, suggests a study that spotlights unnecessary risks to the elderly and a waste of money.

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.